Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2021-10-20 Sale |
2021-10-22 9:42 pm |
4D Molecular Therapeutics Inc. | FDMT | SCHAFFER DAVID Director |
36,285 | $31.36 | $1,137,819 | 901,215 (Direct) |
View |
| 2021-09-29 Sale |
2021-10-01 4:34 pm |
4D Molecular Therapeutics Inc. | FDMT | SCHAFFER DAVID Director |
29,256 | $27.89 | $815,863 | 937,500 (Direct) |
View |
| 2021-09-27 Sale |
2021-09-29 4:05 pm |
4D Molecular Therapeutics Inc. | FDMT | SCHAFFER DAVID Director |
33,244 | $31.9 | $1,060,518 | 966,756 (Direct) |
View |
| 2020-12-15 Purchase |
2020-12-17 9:15 pm |
4D Molecular Therapeutics Inc. | FDMT | VIKING GLOBAL INVESTORS LP Viking Global Opportunities Illiquid Investments Sub-Master LP Viking Global Opportunities Portfolio GP LLC Viking Global Opportunities GP LLC HALVORSEN OLE ANDREAS Ott David C. Shabet Rose Sharon 10% Owner |
1,100,000 | $23 | $25,300,000 | 3,937,914 (Indirect) |
View |
| 2020-12-15 Purchase |
2020-12-17 5:40 pm |
4D Molecular Therapeutics Inc. | FDMT | MILLIGAN JOHN F Director |
100,000 | $23 | $2,300,000 | 100,000 (Indirect) |
View |
| 2020-12-15 Purchase |
2020-12-17 5:40 pm |
4D Molecular Therapeutics Inc. | FDMT | Kamal Fariborz See Remarks |
4,347 | $23 | $99,981 | 4,347 (Direct) |
View |
| 2020-12-15 Purchase |
2020-12-17 5:39 pm |
4D Molecular Therapeutics Inc. | FDMT | YAO TONY DUNG LING Director |
425,000 | $23 | $9,775,000 | 1,063,744 (Indirect Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2022-05-23 Option Award |
2022-05-25 7:05 pm |
N/A 2032-05-22 |
4D Molecular Therapeutics Inc. | FDMT | MILLIGAN JOHN F Director |
33,750 | $0 | 33,750 (Direct) |
View |
| 2022-05-23 Option Award |
2022-05-25 7:02 pm |
N/A 2032-05-22 |
4D Molecular Therapeutics Inc. | FDMT | Miller-Rich Nancy Director |
22,500 | $0 | 22,500 (Direct) |
View |
| 2022-05-23 Option Award |
2022-05-25 7:01 pm |
N/A 2032-05-22 |
4D Molecular Therapeutics Inc. | FDMT | GRAY SUSANNAH Director |
22,500 | $0 | 22,500 (Direct) |
View |
| 2022-05-23 Option Award |
2022-05-25 7:00 pm |
N/A 2032-05-22 |
4D Molecular Therapeutics Inc. | FDMT | Chacko Jacob Director |
22,500 | $0 | 22,500 (Direct) |
View |
Ownership |
2022-03-31 8:17 pm |
N/A 2031-09-30 |
4D Molecular Therapeutics Inc. | FDMT | Bizily Scott Chief Legal Officer |
0 | $0 | 85,000 (Direct) |
View |
| 2022-02-01 Option Award |
2022-02-03 5:43 pm |
N/A 2032-01-31 |
4D Molecular Therapeutics Inc. | FDMT | Moretti August J Chief Financial Officer |
65,000 | $0 | 67,000 (Direct) |
View |
| 2022-02-01 Option Award |
2022-02-03 5:42 pm |
N/A 2032-01-31 |
4D Molecular Therapeutics Inc. | FDMT | Zimmermann Carolyne Chief Business Officer |
35,000 | $0 | 35,000 (Direct) |
View |
| 2022-02-01 Option Award |
2022-02-03 5:40 pm |
N/A 2032-01-31 |
4D Molecular Therapeutics Inc. | FDMT | Kirn David Chief Executive Officer 10% Owner |
150,000 | $0 | 2,150,000 (Direct) |
View |
| 2022-02-01 Option Award |
2022-02-03 5:39 pm |
N/A 2032-01-31 |
4D Molecular Therapeutics Inc. | FDMT | Kamal Fariborz See Remarks |
70,000 | $0 | 70,000 (Direct) |
View |
| 2022-02-01 Option Award |
2022-02-03 5:39 pm |
N/A 2032-01-31 |
4D Molecular Therapeutics Inc. | FDMT | FISHMAN ROBERT S Chief Medical Officer |
65,000 | $0 | 65,000 (Direct) |
View |
| 2021-06-07 Option Award |
2021-06-09 8:28 pm |
N/A 2031-06-06 |
4D Molecular Therapeutics Inc. | FDMT | Zimmermann Carolyne Chief Business Officer |
60,000 | $0 | 60,000 (Direct) |
View |
| 2021-05-17 Option Award |
2021-05-19 8:36 pm |
N/A 2031-05-16 |
4D Molecular Therapeutics Inc. | FDMT | THEUER CHARLES Director |
22,500 | $0 | 22,500 (Direct) |
View |
| 2021-05-17 Option Award |
2021-05-19 8:34 pm |
N/A 2031-05-16 |
4D Molecular Therapeutics Inc. | FDMT | SCHAFFER DAVID Director |
22,500 | $0 | 22,500 (Direct) |
View |
| 2021-05-17 Option Award |
2021-05-19 8:33 pm |
N/A 2031-05-16 |
4D Molecular Therapeutics Inc. | FDMT | Chacko Jacob Director |
22,500 | $0 | 22,500 (Direct) |
View |
| 2021-05-17 Option Award |
2021-05-19 8:33 pm |
N/A 2031-05-16 |
4D Molecular Therapeutics Inc. | FDMT | MILLIGAN JOHN F Director |
33,750 | $0 | 33,750 (Direct) |
View |
| 2021-05-17 Option Award |
2021-05-19 8:32 pm |
N/A 2031-05-16 |
4D Molecular Therapeutics Inc. | FDMT | Miller-Rich Nancy Director |
22,500 | $0 | 22,500 (Direct) |
View |
| 2021-05-17 Option Award |
2021-05-19 8:31 pm |
N/A 2031-05-16 |
4D Molecular Therapeutics Inc. | FDMT | Tomasello Shawn Director |
22,500 | $0 | 22,500 (Direct) |
View |
| 2021-05-17 Option Award |
2021-05-19 8:30 pm |
N/A 2031-05-16 |
4D Molecular Therapeutics Inc. | FDMT | GRAY SUSANNAH Director |
22,500 | $0 | 22,500 (Direct) |
View |
| 2021-04-12 Exercise |
2021-04-14 4:32 pm |
N/A N/A |
4D Molecular Therapeutics Inc. | FDMT | Moretti August J Chief Financial Officer |
1,000 | $9.41 | 225,060 (Direct) |
View |
| 2021-04-12 Exercise |
2021-04-14 4:32 pm |
N/A 2029-03-19 |
4D Molecular Therapeutics Inc. | FDMT | Moretti August J Chief Financial Officer |
1,000 | $0 | 225,060 (Direct) |
View |
| 2021-03-08 Option Award |
2021-03-10 4:06 pm |
N/A 2031-03-07 |
4D Molecular Therapeutics Inc. | FDMT | Kamal Fariborz See Remarks |
60,000 | $0 | 60,000 (Direct) |
View |
| 2021-03-08 Option Award |
2021-03-10 4:05 pm |
N/A 2031-03-07 |
4D Molecular Therapeutics Inc. | FDMT | Kirn David See Remarks 10% Owner |
150,000 | $0 | 150,000 (Direct) |
View |
| 2021-03-08 Option Award |
2021-03-10 4:04 pm |
N/A 2031-03-07 |
4D Molecular Therapeutics Inc. | FDMT | Moretti August J See Remarks |
70,000 | $0 | 70,000 (Direct) |
View |
| 2020-12-15 Conversion |
2020-12-17 9:15 pm |
N/A N/A |
4D Molecular Therapeutics Inc. | FDMT | VIKING GLOBAL INVESTORS LP Viking Global Opportunities Illiquid Investments Sub-Master LP Viking Global Opportunities Portfolio GP LLC Viking Global Opportunities GP LLC HALVORSEN OLE ANDREAS Ott David C. Shabet Rose Sharon 10% Owner |
2,837,914 | $0 | 3,937,914 (Indirect) |
View |
| 2020-12-15 Conversion |
2020-12-17 5:39 pm |
N/A N/A |
4D Molecular Therapeutics Inc. | FDMT | YAO TONY DUNG LING Director |
638,744 | $0 | 1,063,744 (Direct) |
View |
Ownership(A) |
2020-12-17 5:38 pm |
N/A N/A |
4D Molecular Therapeutics Inc. | FDMT | YAO TONY DUNG LING Director |
0 | $0 | 638,744 (Direct) |
View |
Ownership |
2020-12-10 8:14 pm |
N/A 2030-11-11 |
4D Molecular Therapeutics Inc. | FDMT | Miller-Rich Nancy Director |
0 | $0 | 45,000 (Direct) |
View |
Ownership |
2020-12-10 8:08 pm |
N/A N/A |
4D Molecular Therapeutics Inc. | FDMT | VIKING GLOBAL INVESTORS LP Viking Global Opportunities Illiquid Investments Sub-Master LP Viking Global Opportunities Portfolio GP LLC Viking Global Opportunities GP LLC HALVORSEN OLE ANDREAS Ott David C. Shabet Rose Sharon 10% Owner |
0 | $0 | 2,837,914 (Indirect) |
View |
Ownership |
2020-12-10 7:19 pm |
N/A N/A |
4D Molecular Therapeutics Inc. | FDMT | YAO TONY DUNG LING Director |
0 | $0 | 2,864 (Direct) |
View |
Ownership |
2020-12-10 7:18 pm |
N/A 2030-11-11 |
4D Molecular Therapeutics Inc. | FDMT | Tomasello Shawn Director |
0 | $0 | 45,000 (Direct) |
View |
Ownership |
2020-12-10 7:18 pm |
N/A N/A |
4D Molecular Therapeutics Inc. | FDMT | THEUER CHARLES Director |
0 | $0 | 100,368 (Direct) |
View |
Ownership |
2020-12-10 7:17 pm |
N/A N/A |
4D Molecular Therapeutics Inc. | FDMT | SCHAFFER DAVID Director 10% Owner |
0 | $0 | 2,000,000 (Indirect) |
View |
Ownership |
2020-12-10 7:16 pm |
N/A N/A |
4D Molecular Therapeutics Inc. | FDMT | Moretti August J See Remarks |
0 | $0 | 225,060 (Direct) |
View |
Ownership |
2020-12-10 7:16 pm |
N/A 2030-09-16 |
4D Molecular Therapeutics Inc. | FDMT | MILLIGAN JOHN F Director |
0 | $0 | 335,243 (Direct) |
View |
Ownership |
2020-12-10 7:15 pm |
N/A N/A |
4D Molecular Therapeutics Inc. | FDMT | Kirn David See Remarks 10% Owner |
0 | $0 | 2,000,000 (Direct) |
View |